| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $87.67B | $75.37B | $62.11B |
| YoY Revenue Growth % | +16.3% | +21.4% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $13.34B | $10.01B | $4.61B |
| Operating Margin % | 15.2% | 13.3% | 7.4% |
| Net Income (GAAP) | $11.31B | $8.48B | $3.90B |
| EBITDA (Normalized) | $13.62B | $10.23B | $6.84B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $17.55B | $15.12B | $10.64B |
| Capital Expenditures (CapEx) | $348.0M | $285.0M | $2.79B |
| Free Cash Flow (FCF) | $17.20B | $14.83B | $7.85B |
| FCF Margin % | 19.6% | 19.7% | 12.6% |
| Return on Invested Capital (ROIC %) | 18.0% | 15.8% | 8.1% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $41.72B | $36.07B | $17.44B |
| Total Stockholders' Equity | $30.32B | $25.59B | $35.77B |